Dehydroevodiamine targeting IKKβ to alleviate acute gastric injury via inhibiting the p65/NLRP3 axis
Q Hu, Y Chen, W Zhang, Y Li, X Deng, L Chen, Z Zhou… - Phytomedicine, 2024 - Elsevier
Background Acute gastric injury, a common and recurring global digestive disorder,
significantly impairs patient quality of life and overall health. Dehydroevodiamine (DHE), a …
significantly impairs patient quality of life and overall health. Dehydroevodiamine (DHE), a …
Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
J Braun, K Karberg - Exploration of Musculoskeletal Diseases, 2024 - explorationpub.com
Immune checkpoint inhibitors (ICI) such as cytotoxic T-lymphocyte associated protein-4
(CTLA-4), programmed cell death-1 (PD-1), programmed death ligand-1 (PD-L1), and …
(CTLA-4), programmed cell death-1 (PD-1), programmed death ligand-1 (PD-L1), and …